Cheng, T. F., Wang, J. D., & Uen, W. C. (2012). Cost-utility analysis of adjuvant goserelin (Zoladex) and adjuvant chemotherapy in premenopausal women with breast cancer. BioMed Central.
Chicago ZitierstilCheng, Tsui Fen, Jung Der Wang, und Wu Ching Uen. Cost-utility Analysis of Adjuvant Goserelin (Zoladex) and Adjuvant Chemotherapy in Premenopausal Women With Breast Cancer. BioMed Central, 2012.
MLA ZitierstilCheng, Tsui Fen, Jung Der Wang, und Wu Ching Uen. Cost-utility Analysis of Adjuvant Goserelin (Zoladex) and Adjuvant Chemotherapy in Premenopausal Women With Breast Cancer. BioMed Central, 2012.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.